Brokerages Set Crescent Capital BDC, Inc. (NASDAQ:CCAP) Price Target at $19.17

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) has received an average rating of “Moderate Buy” from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $19.17.

Several equities research analysts recently weighed in on CCAP shares. LADENBURG THALM/SH SH began coverage on shares of Crescent Capital BDC in a research report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective for the company. Keefe, Bruyette & Woods boosted their target price on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Monday, November 25th.

Read Our Latest Stock Report on CCAP

Crescent Capital BDC Stock Down 1.5 %

NASDAQ CCAP opened at $18.52 on Wednesday. The company has a 50 day moving average of $19.18 and a 200-day moving average of $18.76. The company has a market cap of $686.39 million, a price-to-earnings ratio of 7.26 and a beta of 0.81. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.14. Crescent Capital BDC has a 1-year low of $15.91 and a 1-year high of $20.03.

Crescent Capital BDC Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 31st will be paid a $0.42 dividend. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.68 annualized dividend and a dividend yield of 9.07%. Crescent Capital BDC’s payout ratio is currently 65.88%.

Institutional Trading of Crescent Capital BDC

Institutional investors have recently bought and sold shares of the company. Janney Montgomery Scott LLC boosted its position in Crescent Capital BDC by 174.1% during the third quarter. Janney Montgomery Scott LLC now owns 47,264 shares of the company’s stock valued at $874,000 after acquiring an additional 30,018 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of Crescent Capital BDC by 35.2% in the 3rd quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock worth $4,726,000 after acquiring an additional 66,713 shares during the last quarter. Stifel Financial Corp increased its stake in Crescent Capital BDC by 53.1% in the 3rd quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock valued at $1,230,000 after buying an additional 23,055 shares during the last quarter. Sun Life Financial Inc. increased its stake in Crescent Capital BDC by 20.7% in the 3rd quarter. Sun Life Financial Inc. now owns 2,226,308 shares of the company’s stock valued at $41,187,000 after buying an additional 382,542 shares during the last quarter. Finally, International Assets Investment Management LLC purchased a new stake in Crescent Capital BDC in the 3rd quarter valued at about $1,899,000. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

(Get Free Report

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.